Keywords: bioalliance, starts, ph, iii, loramyc, trial, usa

BioAlliance starts Ph III Loramyc trial in USA

Article | 22 May 2006

French drugmaker BioAlliance Pharma has commenced a pivotal Phase III US trial of its antifungal agent, Loramyc (miconazole). BioAlliance, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Miconazole

Monistat-Derm

Go to drug listing